Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...

Q3 2024 Earnings Call Transcript November 4, 2024 Operator: Good afternoon. My name is Dilem, and I’ll be your conference ...

Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inspire Medical Systems Inc (INSP) reports a 33% revenue increase and strategic expansions, while addressing potential Q4 ...

“Further, a key peer-reviewed study was published demonstrating the long-term safety of Inspire therapy assessing real-world experience since original FDA approval in 2014.” Revenue was $203.2 ...

“We are very proud of how the team executed in the third quarter, effectively treating patients with Inspire therapy, bringing the total number of patients treated to over 85,000. This ...

Let's start with what is most important and that is the delivery of safe and effective therapy to our patients. And as of this call, we have surpassed 85,000 patients who have received Inspire ...

“During the third quarter, we attended the International Surgical Sleep Society (ISSS) and American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) meetings in Miami where Inspire therapy ...